HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $235,000 | -68.7% | 410,189 | -29.5% | 0.04% | -56.6% |
Q1 2022 | $751,000 | +19.2% | 582,137 | +5.2% | 0.10% | +5.3% |
Q4 2021 | $630,000 | -25.6% | 553,273 | 0.0% | 0.09% | +56.7% |
Q3 2021 | $847,000 | -68.7% | 553,273 | -59.5% | 0.06% | -72.6% |
Q2 2021 | $2,703,000 | – | 1,365,059 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PVG ASSET MANAGEMENT CORP | 51,989 | $79,543,000 | 0.24% |
ASSET MANAGEMENT CORP /IL/ /ADV | 133,500 | $204,000 | 0.10% |
Ikarian Capital, LLC | 553,273 | $847,000 | 0.06% |
McAdam, LLC | 55,978 | $86,000 | 0.01% |
JGP Wealth Management, LLC | 15,000 | $23,000 | 0.01% |
Prospera Financial Services Inc | 30,300 | $46,000 | 0.00% |
Fort Point Capital Partners LLC | 10,000 | $15,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 55,599 | $85,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 6,501 | $10,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,800 | $76,000 | 0.00% |